How the drug-addicted William Burroughs inspired a world-renowned Parkinson’s professor
Author: Susanna LindvallPublished: 13 October 2016
Prep: Cook: Serves:
As a leading figure in the ‘Beat Generation’, US writerWilliam S Burroughs prompted many creatives and scientists to experiment with mind-altering drugs. Professor Andrew Lees, a leading Parkinson’s researcher, was among those drawn to Burroughs’ radical thinking – as chronicled in his new book ‘Mentored by a Madman’. In this exclusive review, Susanna Lindvall, vice-president of the European Parkinson’s Disease Association, praises Lees’ “fearlessness” and expresses hope that his example will encourage more doctors and scientists to be “open-minded and free”
Professor Andrew Lees’ new book Mentored by a Madman: The William Burroughs Experiment, is not only entertaining, it’s also very direct and enlightening. We learn Professor Lees’ personal story, and how this pioneer of Parkinson’s research has been profoundly influenced by William Burroughs’ life and works. It has been written for everyone involved in the push to find better treatments for Parkinson’s disease.
Lees and Burroughs never met, but the effect of the latter is obvious and Lees most generously attributes Burroughs with the ideas behind many of his successful medical insights.
Although Burroughs would have been a questionable neurologist, he has helped Lees find some answers to what his patients so badly need and he has maintained Lees’ curiosity for self-experimentation.
Unsurprisingly, given its use in Parkinson’s therapy, a large part of the book deals with apomorphine. Lees’ personal experience of the drug was positive: “Within a few minutes I started to feel pleasantly relaxed. I did not feel sick and the mild sedative effects disappeared in half an hour”.
We know that Burroughs thought apomorphine was some kind of ‘universal cure’ for society’s ills. He hoped that a powerful, orally active version of the drug, with fewer adverse effects, would become available.
This is not the case today, but Lees and colleagues saw that the administration –continuous delivery by a pump, as opposed to intermittent ‘shots’ – greatly influenced the response of patients. They found that continuous delivery was much more efficacious in smoothing out fluctuations in mood and motor performance (‘on-off’ effects).
Warnings for Parkinson’s medication ‘bureaurocrats’
Lees has never lost touch with the reality of the patient’s experience throughout his career. His way of listening to patients and of taking anecdotal reports seriously is remarkable and should be an inspiration even today. His warnings should also be taken seriously: “Policing of research had become extraordinarily bureaucratic, expensive and confusing. Although ethics committees provided necessary protection against research subjects being harmed, the time researchers now had to spend to obtain approval even for minor amendments to their protocol was lengthy.”
Another concern he raises in the book is over the lack of affordable treatments for Parkinson’s disease. “Some of the useful, cheap drugs that had been approved … like amantadine, benzhexol and Sinemet, kept inexplicably disappearing from pharmacies all over the [UK],” he writes. “Once a drug had become cheap and unprofitable, it was at risk of abandonment even when it was the best available remedy.”
My personal opinion is that Lees is a particularly fearless person who avoids being exhibitionist but bravely reveals sides of himself to inspire new generations of neurologists. The book is a plea to doctors and scientists to be open-minded and free, and also to people with Parkinson’s to fight against unnecessary bureaucracy in research.
All proceeds from the book will go towards Parkinson’s disease research
William Burroughs (1914–1997)
William Seward Burroughs II was an American writer and artist whose work is semi autobiographical, primarily drawn from his experiences as a heroin addict, as he lived throughout Mexico City, London, Paris and Tangier. His confessional first novel, Junkie:Confessions of an Unredeemed Drug Addict (1953), was largely written just after he shot and killed his second wife, Joan Vollmer. Burroughs is perhaps best known for his third novel Naked Lunch (1959), a highly controversial work that seemed to forecast later phenomena such as AIDS, liposuction, and the crack cocaine pandemic.
“We want the world to walk with us,” says Parkinson’s Unity Walk leader
2016 Parkinson’s Unity Walk hopes to raise more than US$1.7m
5 days ago
Researchers have finally identified brain cells linked to Parkinson’s disease
For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…
Tiny DBS implant shows potential to advance Parkinson’s disease treatment
In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”
Could a specialised smartwatch support people with Parkinson’s disease?
A specialised smartwatch, which could help those living with Parkinson’s to better manage their condition, will be rolled out to thousands of people in England. The Parkinson’s Kinetigraph, developed by the National Health Service (NHS) in Plymouth and the University of Plymouth, UK, contains sensors designed to monitor the wearer’s activity and buzz with medication reminders. Data collected from the watch – which detects excessive movement, immobility and sleep disturbances – is shared with healthcare providers, allowing for improvements to physiotherapy and prescriptions based on patient needs. Commenting on the smartwatch’s launch, NHS England chief executive Amanda Pritchard said: “Not only is it better for these people living with Parkinson’s, but it is also more efficient for the NHS, freeing up space and time in hospitals for our hard-working staff.” UK health secretary Sajid Javid, meanwhile, described the Kinetigraph as a “fantastic example of how technology is driving cutting-edge innovation…